Endo Pharmaceuticals (ENDP)
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
Recs
Stock has been under performing the market this year and is trading at a 33% PE discount to the specialty pharma group. Last weeks analyst upgrade should push the price higher.
Recs
I made this pick based of the strong fundamentals of the company. This stock is current rated as one of the best picks out of the 4218 companies analyzed at anticitrade.com. For more information see www.anticitrade.com.
Recs
Endo is poised to make a move up from here. Look for the brokerage houses to ride this baby to ~ $38 prior to the next earnings call. Product sales growth will be on the high side - no "pain" here !
Recs
Joel Greenblatt/Magic Formula pick, 3/30/09
Recs
as long as people are in pain this type of company will survive. these guys are in a good position to do well with the health care reforms that are promised.
Recs
Well, I'm big on fundamentals, especially PEG. I've owned and run small businesses, and I understand the importance of earnings and cash flow. With estimated 2008 earnings of $2.04, $2.57 for 2009, I can confidently hold this stock for a long time knowing that this company is earning me a good ROI. It's also very likely that the market will recognize this, if not this year, then next, and good things will result. Baby boomers are maturing (I'm one of them; born 1957), and we're going to be spending TONS of money on drugs as we age. (Hahaha!)
Recs
I rode IDEV.. might as well keep them running with their new daddy.. This is truly a potential 5-10 bagger
Recs
An aging population will require lots of pain management.
Recs
Drug MFG - Good intrinsic value to price ratio
Recs
Bought at $21.96 and gonna ride it out. I believe this stock will rebound nicely down the road (within 12 to 18 months). In no hurry to let it go.
Recs
Good financials. Seems cheap
Recs
Drug Manufacturers
Recs
Maker of generic pain meds for an ever increasinf population of baby boomers looking for a price break.
Recs
Baby boomers need meds, insurance carriers want generic. i bought this at 16.50.
Recs
In this climate and this sector. ENDP is way overpriced.
Recs
Magical Hat Equation
Recs
Pharmaceuticals is a growth industry and Endo has a good pain management portfolio.
Recs
caps 5, stockscouter10
Recs
eps acceleration&growth / value / recent price strength (4w)
Recs
generic's are going to be a major part of reducing healthcare costs

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 55 1 2 3 Next »